TY - JOUR
T1 - Grade II astrocytomas are subgrouped by chromosome aberrations
AU - Hirose, Yuichi
AU - Aldape, Kenneth D.
AU - Chang, Susan
AU - Lamborn, Kathleen
AU - Berger, Mitchel S.
AU - Feuerstein, Burt G.
N1 - Funding Information:
The authors acknowledge the excellent technical assistance of Ms. Michelle Takahashi and the help and support of Ms. Malgorzata Pellarin in CGH. This work was supported in part by the National Institutes of Health (NCI) grants CA13525, CA 64898, and CA82103, and funds from the University of California San Francisco (UCSF) and UCSF Academic Senate, the North American Brain Tumor Consortium, and the National Brain Tumor Foundation.
PY - 2003/4/1
Y1 - 2003/4/1
N2 - Grade II astrocytoma is defined as a low-grade tumor, yet patients have a wide range of survival and tumors can quickly progress to high-grade astrocytoma/glioblastoma. Previous studies using comparative genomic hybridization (CGH) failed to demonstrate frequent copy number aberrations (CNA) in these tumors. This may be related to technical difficulties because infiltrating astrocytic tumors are often intermixed with normal brain tissue. We developed methods to exclude most normal tissue and use small amounts of DNA for CGH by microdissecting small regions of tumor from paraffin sections and amplifying extracted DNA using degenerate oligonucleotide-primed polymerase chain reaction (DOP-PCR). Using this method, we examined 30 grade II astrocytoma cases. We found CNA in 25 cases (83%), with a mean of two CNA per case. The most frequent CNA were gains on 7q (12 cases), 5p (5 cases), 9 (5 cases), and 19p (3 cases), and losses on 19q (7 cases), 1p (6 cases), and Xp (3 cases). Gain on 7q and losses on 1p/19q were mutually exclusive. This is the first report on the genetic characterization of low-grade astrocytomas using CGH from microdissected and formalin-fixed tissue. The comparatively large number of cases in this study allows us to suggest that these tumors are genetically subgrouped.
AB - Grade II astrocytoma is defined as a low-grade tumor, yet patients have a wide range of survival and tumors can quickly progress to high-grade astrocytoma/glioblastoma. Previous studies using comparative genomic hybridization (CGH) failed to demonstrate frequent copy number aberrations (CNA) in these tumors. This may be related to technical difficulties because infiltrating astrocytic tumors are often intermixed with normal brain tissue. We developed methods to exclude most normal tissue and use small amounts of DNA for CGH by microdissecting small regions of tumor from paraffin sections and amplifying extracted DNA using degenerate oligonucleotide-primed polymerase chain reaction (DOP-PCR). Using this method, we examined 30 grade II astrocytoma cases. We found CNA in 25 cases (83%), with a mean of two CNA per case. The most frequent CNA were gains on 7q (12 cases), 5p (5 cases), 9 (5 cases), and 19p (3 cases), and losses on 19q (7 cases), 1p (6 cases), and Xp (3 cases). Gain on 7q and losses on 1p/19q were mutually exclusive. This is the first report on the genetic characterization of low-grade astrocytomas using CGH from microdissected and formalin-fixed tissue. The comparatively large number of cases in this study allows us to suggest that these tumors are genetically subgrouped.
UR - https://www.scopus.com/pages/publications/0345268776
UR - https://www.scopus.com/pages/publications/0345268776#tab=citedBy
U2 - 10.1016/S0165-4608(02)00791-4
DO - 10.1016/S0165-4608(02)00791-4
M3 - Article
C2 - 12660025
AN - SCOPUS:0345268776
SN - 0165-4608
VL - 142
SP - 1
EP - 7
JO - Cancer Genetics and Cytogenetics
JF - Cancer Genetics and Cytogenetics
IS - 1
ER -
SDG 3 すべての人に健康と福祉を